San Diego, CA, United States of America

Theodore O Johnnson, Jr

This inventor holds 1 USPTO granted patent. Top assignee: Agouron Pharmaceuticals, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theodore O Johnnson, Jr. Retrieved from https://idiyas.com/inventor/theodore-o-johnnson-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Theodore O. Johnnson, Jr.

Introduction

Theodore O. Johnnson, Jr. is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His work has the potential to impact the treatment of viral infections.

Latest Patents

Johnnson holds a patent for "Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis." This patent highlights his innovative approach to combating viral diseases through the development of new pharmaceutical compounds.

Career Highlights

Johnnson is currently employed at Agouron Pharmaceuticals, Inc., where he continues to advance his research in antiviral therapies. His work at Agouron has positioned him as a key player in the pharmaceutical industry, contributing to the development of effective treatments.

Collaborations

Throughout his career, Johnnson has collaborated with esteemed colleagues such as Peter Scott Dragovich and Thomas Jay Prins. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Theodore O. Johnnson, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations are paving the way for advancements in antiviral treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…